Announced Tue, 7 Apr · 11:27 IST
Q4 FY26 dematerialization compliance certificate filed with exchanges
Compliance View source PDF
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹389.00
prior close
₹391.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.2+0.3+1.1+2.8+6.2+7.3+7.2+12.8+10.6+5.9+9.2-5.9+8.5
Up moveDown movePending
AI summary
SMS Pharmaceuticals submitted a certificate under SEBI Regulation 74(5) from its Registrar and Share Transfer Agent, Aarthi Consultants, for the quarter ended 31 March 2026. The certificate confirms that physical share certificates received from depository participants during January–March 2026 were dematerialized, the original certificates were mutilated and cancelled, and the depository was recorded as the registered owner. This is a routine quarterly compliance filing with no business or financial impact.
Likely market impact
Routine regulatory compliance filing; no material impact on operations, financials, or share price.